Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Trial, Comparing EUS Fine Needle Biopsy (EUS-FNB) With Rapid On-Site Evaluation (ROSE) Versus EUS-FNB Alone for the Evaluation of Patients With Solid Pancreatic Lesions

NCT03322592 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Integrata Verona as lead sponsor.

NCT NCT03322592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03322592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Trial, Comparing EUS Fine Needle Biopsy (EUS-FNB) With Rapid On-Site Evaluation (ROSE) Versus EUS-FNB Alone for the Evaluation of Patients With Solid Pancreatic Lesions
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Phase
Not applicable
Overall status
Completed
Start date
March 29, 2018
Completion date
July 30, 2020
Enrollment
800 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

biopsy, fine-needle, pancreatic neoplasm